Hospital Acquired Infection Control Industry Is Expand at a CAGR of 3.5% to Reach USD 26.8 billion by 2031

The Hospital Acquired Infection Control Market was valued at USD 19.0 billion in 2021 and it is anticipated to grow further up to USD 26.8 billion by 2031, at a CAGR of 3.5% during the forecast period.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10297

Nosocomially acquired illnesses that are not present or incubating at the time of admission to a hospital are known as hospital-acquired infections (HAIs). These infections include bloodstream infections linked to central lines, urinary tract infections linked to catheters, surgical site infections, pneumonia linked to ventilators, pneumonia acquired in hospitals, and infections with Clostridium difficile. A productive cough, shortness of breath, abdominal discomfort, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness are signs that an infection is present.

Read more about Hospital Acquired Infection Control market here: https://www.globalinsightservices.com/reports/hospital-acquired-infection-control-market/

Major Players of the Global Hospital Acquired Infection Control Market

The key players analyzed in the market are Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, and Bayer AG among others.

Global Hospital Acquired Infection Control Market Segmentation

By Products & Services

Sterilization

Cleaning & Disinfection Products

Protective Barriers

Endoscope Reprocessing Products

By Infection Type

Hospital-acquired Pneumonia

Bloodstream Infections

Surgical Site Infections

Gastrointestinal Infections

Urinary Tract Infections (UTI)

Others

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10297

Market Trends and Drivers

Some of the major factors driving this market are rising awareness about Hospital Acquired Infections (HAIs), the need to prevent cross-infections, the incidence of infectious diseases in healthcare facilities, and supportive government programs to encourage infection control techniques. The development of national, regional, and hospital-level infection prevention guidelines and policies as well as the expanding use of monitoring tools are both contributing to the expansion. Similarly, the market for hospital-acquired infection control is anticipated to grow as a result of factors including the increased demand for sterilization and disinfection in hospitals and clinics, technological developments in sterilization and disinfection equipment, an increase in hospitals outsourcing sterilization services to pharmaceutical and medical device companies, and an increase in the production of medical nonwovens and single-use products due to an increase in COVID-19 cases.

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10297

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

This release was published on openPR.